| |
|
|
|
OncoSec Medical Incorporated  
|
|
2.29 0.18 (0.09%) |
09-17 16:00 |
|
Open: |
2.12 |
Pre close: |
2.11 |
Target:
|
2.71
|
|
High: |
2.31 |
Low: |
2.12 |
Resistance:
|
2.32
2.71
|
|
Volume: |
139,802 |
Market Cap: |
24M |
Support:
|
2.00
1.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.07
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.99 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
2.82  |
Stochastic Oscillator |
%K(14,3):
|
75.89 |
|
MA(250): |
6.42 |
%D(3): |
59.80 |
|
Average Volume(K) |
3-Month: |
10094
|
52-Week |
High:
|
19.60 |
|
10-Days: |
7004 |
Low: |
1.80 |
|
RSI |
RSI(14):
|
62.38 |
Change(%): |
-82.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-5.931 |
Return on Equity (ttm) |
-130.7 |
Shares Out. (M) |
10.62 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
-68.5 |
Shares Float (M) |
7.39 |
|
EPS Est. Next Year |
-0.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
18.21 |
|
EPS Est. Next Quarter |
-0.260 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
6.40 |
|
Forward EPS |
-0.670 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
104 |
|
Book Value (p.s.) |
2.980 |
EBITDA (p.s.) |
-3.282 |
P/E |
-0.39 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.77 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-27.13 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-13.14 |
P/CF |
-0.90 |
|
|
|
|
|
|
